Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oralgen SLIT for Grass Pollen Allergy
NCT00150514Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2002
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Oralgen Grass Pollen in seasonal allergic rhinitis (SAR), sponsored by Radboud University Medical Center. Started Jan 2002; status: completed.
02
Drugs
Oralgen Grass Pollen
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00150514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150514.